Financial Advocates Investment Management Purchases 3,376 Shares of Relx Plc $RELX

Financial Advocates Investment Management raised its position in shares of Relx Plc (NYSE:RELX) by 53.9% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 9,643 shares of the technology company’s stock after acquiring an additional 3,376 shares during the period. Financial Advocates Investment Management’s holdings in Relx were worth $524,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently made changes to their positions in the business. HB Wealth Management LLC lifted its position in shares of Relx by 124.6% during the 1st quarter. HB Wealth Management LLC now owns 19,671 shares of the technology company’s stock worth $992,000 after purchasing an additional 10,913 shares during the last quarter. LPL Financial LLC grew its holdings in Relx by 9.5% in the 1st quarter. LPL Financial LLC now owns 252,566 shares of the technology company’s stock valued at $12,732,000 after buying an additional 21,977 shares during the last quarter. Fiera Capital Corp increased its position in Relx by 22.9% in the 1st quarter. Fiera Capital Corp now owns 10,411 shares of the technology company’s stock worth $525,000 after buying an additional 1,941 shares during the period. Natixis Advisors LLC lifted its holdings in shares of Relx by 0.5% during the first quarter. Natixis Advisors LLC now owns 1,208,467 shares of the technology company’s stock worth $60,919,000 after buying an additional 5,875 shares during the last quarter. Finally, Cordatus Wealth Management LLC acquired a new position in shares of Relx during the first quarter worth approximately $575,000. 15.02% of the stock is owned by institutional investors and hedge funds.

Relx Stock Performance

Shares of NYSE:RELX opened at $40.19 on Thursday. Relx Plc has a 12 month low of $39.31 and a 12 month high of $56.33. The company’s 50-day moving average price is $44.46 and its two-hundred day moving average price is $48.95. The company has a debt-to-equity ratio of 2.55, a current ratio of 0.47 and a quick ratio of 0.42.

Wall Street Analyst Weigh In

Several equities research analysts have recently issued reports on RELX shares. Barclays restated an “overweight” rating on shares of Relx in a research note on Tuesday, October 7th. Kepler Capital Markets upgraded shares of Relx from a “hold” rating to a “strong-buy” rating in a research report on Thursday, September 18th. Weiss Ratings restated a “hold (c+)” rating on shares of Relx in a report on Tuesday. Morgan Stanley reiterated an “overweight” rating on shares of Relx in a research note on Thursday, September 11th. Finally, Wall Street Zen downgraded Relx from a “buy” rating to a “hold” rating in a research report on Saturday, November 8th. One investment analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating and one has issued a Hold rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Buy”.

Relx Company Profile

RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.